This brief slideshow provides concise summaries of key findings in recent studies.
Efficacy and Safety of Fremanezumab Consistent in Patients With Migraine and Obesity
Episode 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings
Long-Term Atogepant Effective, Safe as Migraine Preventive, Open-Label Studies Show
Episode 88: 2023 AAN Annual Meeting Highlights
NeurologyLive® Brain Games: April 14, 2024
Pooled Phase 3 Studies Highlight AXS-07 as Effective Migraine Treatment
